Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

252

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

July 5, 2024

Study Completion Date

October 23, 2025

Conditions

Healthy

Interventions

DRUG

Polyene Phosphatidylcholine

Formulated as an injectable solution containing Polyene Phosphatidylcholine at concentration of 25 mg/mL

DRUG

Matching placebo of AYP-101

Phosphate buffered saline placebo for injection

Trial Locations (1)

Chung-Ang University Hosptial, Seoul

All Listed Sponsors

lead

AMIpharm Co., Ltd.

INDUSTRY

NCT06256445 - Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area | Biotech Hunter | Biotech Hunter